Home2162 • HKG
add
Keymed Biosciences Inc
Previous close
$64.50
Day range
$63.55 - $65.95
Year range
$27.05 - $80.00
Market cap
19.70B HKD
Avg Volume
2.97M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 249.38M | 812.10% |
Operating expense | 299.80M | 34.93% |
Net income | -39.42M | 76.59% |
Net profit margin | -15.81 | 97.43% |
Earnings per share | — | — |
EBITDA | -46.98M | 73.59% |
Effective tax rate | -4.14% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.80B | 8.52% |
Total assets | 4.63B | 21.69% |
Total liabilities | 1.44B | 22.88% |
Total equity | 3.20B | — |
Shares outstanding | 294.60M | — |
Price to book | 5.95 | — |
Return on assets | -3.63% | — |
Return on capital | -4.13% | — |
Cash Flow
Net change in cash
(CNY) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -39.42M | 76.59% |
Cash from operations | -90.48M | 50.55% |
Cash from investing | -99.85M | -400.99% |
Cash from financing | 442.75M | 235.51% |
Net change in cash | 261.65M | 470.83% |
Free cash flow | -86.58M | 41.59% |
About
CEO
Founded
Sep 2016
Website
Employees
1,469